Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Metabotropic Glutamate Receptor 2 Market by Type (LY-2607540, BMT-133218, DT-2442, JNJ-40411813, Others), By Application (Anxiety Disorders, Depression, Schizophrenia, Chronic Pain, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Metabotropic Glutamate Receptor 2 Market by Type (LY-2607540, BMT-133218, DT-2442, JNJ-40411813, Others), By Application (Anxiety Disorders, Depression, Schizophrenia, Chronic Pain, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 131927 3300 Pharma & Healthcare 377 235 Pages 4.6 (33)
                                          

Industry Growth Insights published a new data on “Metabotropic Glutamate Receptor 2 Market”. The research report is titled “Metabotropic Glutamate Receptor 2 Market research by Types (LY-2607540, BMT-133218, DT-2442, JNJ-40411813, Others), By Applications (Anxiety Disorders, Depression, Schizophrenia, Chronic Pain, Others), By Players/Companies Addex Therapeutics Ltd, Bristol-Myers Squibb Company, Denovo Biopharma LLC, Domain Therapeutics SA, Eli Lilly and Company, Johnson & Johnson, Merck & Co Inc, ...”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Metabotropic Glutamate Receptor 2 Market Research Report

By Type

LY-2607540, BMT-133218, DT-2442, JNJ-40411813, Others

By Application

Anxiety Disorders, Depression, Schizophrenia, Chronic Pain, Others

By Companies

Addex Therapeutics Ltd, Bristol-Myers Squibb Company, Denovo Biopharma LLC, Domain Therapeutics SA, Eli Lilly and Company, Johnson & Johnson, Merck & Co Inc, ...

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

235

Number of Tables & Figures

165

Customization Available

Yes, the report can be customized as per your need.


Global Metabotropic Glutamate Receptor 2 Industry Outlook


Global Metabotropic Glutamate Receptor 2 Market Report Segments:

The global Metabotropic Glutamate Receptor 2 market is segmented on the basis of:

Types

LY-2607540, BMT-133218, DT-2442, JNJ-40411813, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Anxiety Disorders, Depression, Schizophrenia, Chronic Pain, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Addex Therapeutics Ltd
  2. Bristol-Myers Squibb Company
  3. Denovo Biopharma LLC
  4. Domain Therapeutics SA
  5. Eli Lilly and Company
  6. Johnson & Johnson
  7. Merck & Co Inc
  8. ...

Global Metabotropic Glutamate Receptor 2 Market Overview


Highlights of The Metabotropic Glutamate Receptor 2 Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. LY-2607540
    2. BMT-133218
    3. DT-2442
    4. JNJ-40411813
    5. Others
  1. By Application:

    1. Anxiety Disorders
    2. Depression
    3. Schizophrenia
    4. Chronic Pain
    5. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Metabotropic Glutamate Receptor 2 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Metabotropic Glutamate Receptor 2 Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Metabotropic Glutamate Receptor 2 Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Metabotropic Glutamate Receptor 2 Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Metabotropic Glutamate Receptor 2 Market - Supply Chain
   4.5. Global Metabotropic Glutamate Receptor 2 Market Forecast
      4.5.1. Metabotropic Glutamate Receptor 2 Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Metabotropic Glutamate Receptor 2 Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Metabotropic Glutamate Receptor 2 Market Absolute $ Opportunity

5. Global Metabotropic Glutamate Receptor 2 Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Type
      5.3.1. LY-2607540
      5.3.2. BMT-133218
      5.3.3. DT-2442
      5.3.4. JNJ-40411813
      5.3.5. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Metabotropic Glutamate Receptor 2 Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Application
      6.3.1. Anxiety Disorders
      6.3.2. Depression
      6.3.3. Schizophrenia
      6.3.4. Chronic Pain
      6.3.5. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Metabotropic Glutamate Receptor 2 Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Metabotropic Glutamate Receptor 2 Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Metabotropic Glutamate Receptor 2 Demand Share Forecast, 2019-2029

9. North America Metabotropic Glutamate Receptor 2 Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Application
      9.4.1. Anxiety Disorders
      9.4.2. Depression
      9.4.3. Schizophrenia
      9.4.4. Chronic Pain
      9.4.5. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Type
      9.7.1. LY-2607540
      9.7.2. BMT-133218
      9.7.3. DT-2442
      9.7.4. JNJ-40411813
      9.7.5. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Metabotropic Glutamate Receptor 2 Demand Share Forecast, 2019-2029

10. Latin America Metabotropic Glutamate Receptor 2 Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Application
      10.4.1. Anxiety Disorders
      10.4.2. Depression
      10.4.3. Schizophrenia
      10.4.4. Chronic Pain
      10.4.5. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Type
      10.7.1. LY-2607540
      10.7.2. BMT-133218
      10.7.3. DT-2442
      10.7.4. JNJ-40411813
      10.7.5. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Metabotropic Glutamate Receptor 2 Demand Share Forecast, 2019-2029

11. Europe Metabotropic Glutamate Receptor 2 Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Application
      11.4.1. Anxiety Disorders
      11.4.2. Depression
      11.4.3. Schizophrenia
      11.4.4. Chronic Pain
      11.4.5. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Type
      11.7.1. LY-2607540
      1.7.2. BMT-133218
      11.7.3. DT-2442
      11.7.4. JNJ-40411813
      11.7.5. Others
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Metabotropic Glutamate Receptor 2 Demand Share, 2019-2029

12. Asia Pacific Metabotropic Glutamate Receptor 2 Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Application
      12.4.1. Anxiety Disorders
      12.4.2. Depression
      12.4.3. Schizophrenia
      12.4.4. Chronic Pain
      12.4.5. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Type
      12.7.1. LY-2607540
      12.7.2. BMT-133218
      12.7.3. DT-2442
      12.7.4. JNJ-40411813
      12.7.5. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Metabotropic Glutamate Receptor 2 Demand Share, 2019-2029

13. Middle East & Africa Metabotropic Glutamate Receptor 2 Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Application
      13.4.1. Anxiety Disorders
      13.4.2. Depression
      13.4.3. Schizophrenia
      13.4.4. Chronic Pain
      13.4.5. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Metabotropic Glutamate Receptor 2 Market Size and Volume Forecast by Type
      13.7.1. LY-2607540
      13.7.2. BMT-133218
      13.7.3. DT-2442
      13.7.4. JNJ-40411813
      13.7.5. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Metabotropic Glutamate Receptor 2 Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Metabotropic Glutamate Receptor 2 Market: Market Share Analysis
   14.2. Metabotropic Glutamate Receptor 2 Distributors and Customers
   14.3. Metabotropic Glutamate Receptor 2 Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Addex Therapeutics Ltd
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Bristol-Myers Squibb Company
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Denovo Biopharma LLC
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Domain Therapeutics SA
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Eli Lilly and Company
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Johnson & Johnson
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Merck & Co Inc
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. ...
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us